Cargando…

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

BACKGROUND: The ‘Asia-Pacific Expert Panel (APEX) for donepezil 23 mg’ met in November 2015 to review evidence for the recently approved high dose of donepezil and to provide recommendations to help physicians in Asia make informed clinical decisions about using donepezil 23 mg in patients with mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabbagh, Marwan, Han, SeolHeui, Kim, SangYun, Na, Hae-Ri, Lee, Jae-Hong, Kandiah, Nagaendran, Phanthumchinda, Kammant, Suthisisang, Chuthamanee, Senanarong, Vorapun, Pai, Ming-Chyi, Narilastri, Diatri, Sowani, Ajit M., Ampil, Encarnita, Dash, Amitabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040883/ https://www.ncbi.nlm.nih.gov/pubmed/27703471 http://dx.doi.org/10.1159/000448214

Ejemplares similares

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah, Nagaendran, et al.
Publicado: (2017)

Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus
por: Kandiah, Nagaendran, et al.
Publicado: (2020)

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761(®)
por: Kandiah, Nagaendran, et al.
Publicado: (2019)

Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia
por: Yaowaluk, Thitipon, et al.
Publicado: (2019)

Thai-version Migraine Disability Assessment (MIDAS) questionnaire: concurrent validity, test–retest reliability, internal consistency, and factors predictive for migraine-related disability
por: Asawavichienjinda, Thanin, et al.
Publicado: (2020)

High burden of cerebral white matter lesion in 9 Asian cities
por: Lam, Bonnie Yin Ka, et al.
Publicado: (2021)

Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2018)

Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer’s Disease
por: Senanarong, Vorapun, et al.
Publicado: (2020)

Clinical presentations and treatment outcomes of Hashimoto encephalopathy at Siriraj Hospital – Thailand’s largest national tertiary referral center
por: Dumrikarnlert, Chaisak, et al.
Publicado: (2023)

Traditional Medicine for Treatment of Neurodegenerative Diseases
por: Wu, Chun Fu, et al.
Publicado: (2014)

Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist–physician collaboration in the outpatient department
por: Sathienluckana, Thanompong, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics studies of a loading dose of cisatracurium in critically ill patients with respiratory failure
por: Panusitthikorn, Panadda, et al.
Publicado: (2022)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
por: Sabbagh, Marwan, et al.
Publicado: (2011)

Clinical Aspects of Neurobehavioral Symptoms of Dementia
por: Yang, YoungSoon, et al.
Publicado: (2020)

Action observation combined with gait training to improve gait and cognition in elderly with mild cognitive impairment A randomized controlled trial
por: Rojasavastera, Rommanee, et al.
Publicado: (2020)

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
por: Park, Kee Hyung, et al.
Publicado: (2021)

Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen
por: Thavichachart, N, et al.
Publicado: (2006)

Calpainopathy (Leyden-Mobius Limb-Girdle Muscular Dystrophy Type 2A Phenotype) and Dysferlinopathy (Miyoshi Distal Myopathy Limb-Girdle Muscular Dystrophy Type 2B Phenotype) of Preadolescent Onset: Case Reports of Two Male Filipinos
por: Quilacio, Joanna May S, et al.
Publicado: (2022)

A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers
por: Sabbagh, Marwan N., et al.
Publicado: (2023)

Quantitative gait analysis in mild cognitive impairment, dementia, and cognitively intact individuals: a cross-sectional case–control study
por: Bovonsunthonchai, Sunee, et al.
Publicado: (2022)

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response
por: Sabbagh, Marwan, et al.
Publicado: (2013)

Corrigendum to “Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience”
por: Senanarong, Vorapun, et al.
Publicado: (2017)

Accuracy of Support-Vector Machines for Diagnosis of Alzheimer's Disease, Using Volume of Brain Obtained by Structural MRI at Siriraj Hospital
por: Vichianin, Yudthaphon, et al.
Publicado: (2021)

Efficacy and economic evaluation of delivery of care with tele-continuous EEG in critically ill patients: a multicentre, randomised controlled trial (Tele-cRCT) study protocol
por: Limotai, Chusak, et al.
Publicado: (2020)

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity
por: Ferris, Steven, et al.
Publicado: (2013)

Cognitive impairments predict the behavioral and psychological symptoms of dementia
por: Hemrungrojn, Solaphat, et al.
Publicado: (2023)

HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria
por: Chan, Lai Gwen, et al.
Publicado: (2012)

Frontotemporal Dementia in Southeast Asia: A Comparative Study
por: Tan, Yee-Leng, et al.
Publicado: (2013)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia
por: Dominguez, Jacqueline Cotoong, et al.
Publicado: (2022)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai, Ming-Chyi, et al.
Publicado: (2015)

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Association of physical activity with dementia and cognitive decline in UK Biobank
por: Huang, Xiangyuan, et al.
Publicado: (2023)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)
por: Lang, Frederick M., et al.
Publicado: (2021)

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iqqb6qq6j2bp9u86e1j6920ri1